3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
115
Breast Neoplasms
114
Ovarian Neoplasms
72
Triple Negative Breast Neoplasms
57
Fallopian Tube Neoplasms
43
Endometrial Neoplasms
42
Lung Neoplasms
40
Squamous Cell Carcinoma of Head and Neck
39
Neoplasm Metastasis
36
Stomach Neoplasms
28
Neoplasms
28
Parkinson Disease 4, Autosomal Dominant Lewy Body
27
Esophageal Neoplasms
22
Esophageal Squamous Cell Carcinoma
21
Head and Neck Neoplasms
16
Carcinoma
16
Uterine Cervical Neoplasms
15
Carcinoma, Ovarian Epithelial
15
Colorectal Neoplasms
14
Carcinoma, Squamous Cell
11
Adenocarcinoma
10
Small Cell Lung Carcinoma
9
Melanoma
9
Adenocarcinoma Of Esophagus
9
Peritoneal Neoplasms
8
Oropharyngeal Neoplasms
8
Carcinoma, Transitional Cell
8
Urinary Bladder Neoplasms
7
Pancreatic Neoplasms
7
Mouth Neoplasms
7
Interventions
Bevacizumab
3
contrast agent BR1
2
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Microbubbles
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
Biopsy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Nerve Tissue
×
Paclitaxel
×
1 year
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts